Roivant Sciences Business Segments — Cost of revenues decreased by 54.3% to $320.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 56.1%, from $205.00K to $320.00K. Over 2 years (FY 2023 to FY 2025), Business Segments — Cost of revenues shows a downward trend with a -10.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A decrease relative to revenue suggests improved production efficiency or favorable cost structures.
This includes the direct costs attributable to the production and delivery of products or services sold by the segment....
Commonly benchmarked against peers to assess manufacturing and supply chain efficiency.
roiv_segment_reportable_segment_cost_of_revenues| Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $399.75K | $399.75K | $399.75K | $399.75K | $213.00K | $234.00K | $259.00K | $205.00K | $154.00K | $111.00K | $700.00K | $320.00K |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -46.7% | +9.9% | +10.7% | -20.8% | -24.9% | -27.9% | +530.6% | -54.3% |
| YoY Change | — | — | — | — | -46.7% | -41.5% | -35.2% | -48.7% | -27.7% | -52.6% | +170.3% | +56.1% |